Active, not recruitingPhase 3NCT02616484

Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency:

Studying Pyruvate dehydrogenase deficiency

Last synced from ClinicalTrials.gov May 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Saol Therapeutics Inc
Principal Investigator: Richard Neibeger, MD
University of Florida
Intervention: Dichloroacetate (DCA)(drug)
Enrollment: 34 enrolled
Eligibility: 6-17 years · All sexes
Timeline: 2020 – 2025

Study locations (10)

Children's Hospital of Orange County, Orange, California, United States
Stanford University, Stanford, California, United States
Children's National Medical Center, Washington D.C., District of Columbia, United States
University of Florida, Gainesville, Florida, United States
University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
Baylor College of Medicine, Houston, Texas, United States
University of Utah, Salt Lake City, Utah, United States
Seattle Children's Hospital, Seattle, Washington, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02616484 on ClinicalTrials.gov

Other trials for Pyruvate dehydrogenase deficiency

Additional recruiting or active studies for the same condition.

See all trials for Pyruvate dehydrogenase deficiency →

← Back to all trials